用户名: 密码: 验证码:
The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: A double-blind, randomized control trial
详细信息    查看全文
  • 作者:Gerald T Mangine (1)
    Adam M Gonzalez (1)
    Adam J Wells (1)
    William P McCormack (1)
    Maren S Fragala (1)
    Jeffrey R Stout (1)
    Jay R Hoffman (1)
  • 关键词:Dietary Adherence ; Appetite ; Obesity ; Green Tea Extract
  • 刊名:Lipids in Health and Disease
  • 出版年:2012
  • 出版时间:December 2012
  • 年:2012
  • 卷:11
  • 期:1
  • 全文大小:213KB
  • 参考文献:1. Flegal KM, Carroll MD, Ogden CL, Curtin LR: g class="a-plus-plus">Prevalence and trends in obesity among US adults, 1999-008.g> / JAMA 2010, g class="a-plus-plus">303:g>235-41. g/10.1001/jama.2009.2014">CrossRef
    2. National Center for Health Statistics: g class="a-plus-plus">Health, United States, 2011.g> In / Brief. Hyattsville, MD; 2012.
    3. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH: g class="a-plus-plus">Weight, weight change, and coronary heart disease in women. Risk within the ’normal-weight range.g> / JAMA 1995, g class="a-plus-plus">273:g>461-65. g/10.1001/jama.1995.03520300035033">CrossRef
    4. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, / et al.: g class="a-plus-plus">Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study.g> / Lancet 2005, g class="a-plus-plus">366:g>1640-649. g/10.1016/S0140-6736(05)67663-5">CrossRef
    5. Colditz GA, Willett WC, Rotnitzky A, Manson JE: g class="a-plus-plus">Weight gain as a risk factor for clinical diabetes mellitus in women.g> / Ann Intern Med 1995, g class="a-plus-plus">122:g>481-86.
    6. Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K: g class="a-plus-plus">Effects of obesity on respiratory function.g> / Am Rev Respir Dis 1983, g class="a-plus-plus">128:g>501-06.
    7. Janssen I: g class="a-plus-plus">Morbidity and mortality risk associated with an overweight BMI in older men and women.g> / Obesity (Silver Spring) 2007, g class="a-plus-plus">15:g>1827-840. g/10.1038/oby.2007.217">CrossRef
    8. Andreou E, Philippou C, Papandreou D: g class="a-plus-plus">Effects of an Intervention and Maintenance Weight Loss Diet with and without Exercise on Anthropometric Indices in Overweight and Obese Healthy Women.g> / Ann Nutr Metab 2011, g class="a-plus-plus">59:g>187-92. g/10.1159/000334755">CrossRef
    9. Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, Napoli N, Qualls C, Shah K: g class="a-plus-plus">Weight loss, exercise, or both and physical function in obese older adults.g> / N Engl J Med 2011, g class="a-plus-plus">364:g>1218-229. g/10.1056/NEJMoa1008234">CrossRef
    10. Carels RA, Young KM, Coit C, Clayton AM, Spencer A, Hobbs M: g class="a-plus-plus">Can following the caloric restriction recommendations from the Dietary Guidelines for Americans help individuals lose weight?g> / Eat Behav 2008, g class="a-plus-plus">9:g>328-35. g/10.1016/j.eatbeh.2007.12.003">CrossRef
    11. Makris A, Foster GD: g class="a-plus-plus">Dietary approaches to the treatment of obesity.g> / Psychiatr Clin North Am 2011, g class="a-plus-plus">34:g>813-27. g/10.1016/j.psc.2011.08.004">CrossRef
    12. Arterburn D, Noel PH: g class="a-plus-plus">Extracts from “Clinical Evidence- Obesity.g> / BMJ 2001, g class="a-plus-plus">322:g>1406-409. g/10.1136/bmj.322.7299.1406">CrossRef
    13. Barratt R, Frost G, O’Boyle A, Millward J, Truby H: g class="a-plus-plus">Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian’s toolbox.g> / J Hum Nutr Diet 2008, g class="a-plus-plus">21:g>248-55. g/10.1111/j.1365-277X.2008.00870.x">CrossRef
    14. Ioannides-Demos LL, Proietto J, McNeil JJ: g class="a-plus-plus">Pharmacotherapy for obesity.g> / Drugs 2005, g class="a-plus-plus">65:g>1391-418. g/10.2165/00003495-200565100-00006">CrossRef
    15. Perrio MJ, Wilton LV, Shakir SA: g class="a-plus-plus">The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.g> / Obesity (Silver Spring) 2007, g class="a-plus-plus">15:g>2712-722. g/10.1038/oby.2007.323">CrossRef
    16. Manore MM: g class="a-plus-plus">Dietary supplements for improving body composition and reducing body weight: where is the evidence?g> / Int J Sport Nutr Exerc Metab 2012, g class="a-plus-plus">22:g>139-54.
    17. Rondanelli M, Opizzi A, Solerte SB, Trotti R, Klersy C, Cazzola R: g class="a-plus-plus">Administration of a dietary supplement (N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial.g> / Br J Nutr 2009, g class="a-plus-plus">101:g>457-64. g/10.1017/S0007114508024008">CrossRef
    18. Williams CM, Kirkham TC: g class="a-plus-plus">Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.g> / Psychopharmacology (Berl) 1999, g class="a-plus-plus">143:g>315-17. g/10.1007/s002130050953">CrossRef
    19. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodriguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D: g class="a-plus-plus">Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.g> / Nature 2003, g class="a-plus-plus">425:g>90-3. g/10.1038/nature01921">CrossRef
    20. Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, / et al.: g class="a-plus-plus">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents.g> / Cell Metab 2006, g class="a-plus-plus">3:g>167-75. g/10.1016/j.cmet.2006.02.004">CrossRef
    21. Chantre P, Lairon D: g class="a-plus-plus">Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity.g> / Phytomedicine 2002, g class="a-plus-plus">9:g>3-. g/10.1078/0944-7113-00078">CrossRef
    22. Nagao T, Hase T, Tokimitsu I: g class="a-plus-plus">A green tea extract high in catechins reduces body fat and cardiovascular risks in humans.g> / Obesity (Silver Spring) 2007, g class="a-plus-plus">15:g>1473-483. g/10.1038/oby.2007.176">CrossRef
    23. Wang H, Wen Y, Du Y, Yan X, Guo H, Rycroft JA, Boon N, Kovacs EM, Mela DJ: g class="a-plus-plus">Effects of catechin enriched green tea on body composition.g> / Obesity (Silver Spring) 2010, g class="a-plus-plus">18:g>773-79. g/10.1038/oby.2009.256">CrossRef
    24. Zhu BT, Shim JY, Nagai M, Bai HW: g class="a-plus-plus">Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (-)-epigallocatechin-3-O-gallate.g> / Xenobiotica 2008, g class="a-plus-plus">38:g>130-46. g/10.1080/00498250701744641">CrossRef
    25. Borchardt RT, Huber JA: g class="a-plus-plus">Catechol O-methyltransferase. 5. Structure-activity relationships for inhibition by flavonoids.g> / J Med Chem 1975, g class="a-plus-plus">18:g>120-22. g/10.1021/jm00235a030">CrossRef
    26. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS: g class="a-plus-plus">The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.g> / J Nutr 2008, g class="a-plus-plus">138:g>1677-683.
    27. Lonac MC, Richards JC, Schweder MM, Johnson TK, Bell C: g class="a-plus-plus">Influence of short-term consumption of the caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on resting metabolism and the thermic effect of feeding.g> / Obesity (Silver Spring) 2011, g class="a-plus-plus">19:g>298-04. g/10.1038/oby.2010.181">CrossRef
    28. Broccali GBM, Pistolesi E, Cestaro B: g class="a-plus-plus">N-oleoylphosphatidylethanolamine reduces food intake and body weight of dietary obese rats ameliorating their antioxidant status.g> / Gazzeta Medica Italiana Archivo Per Le Scienze Mediche 2005, g class="a-plus-plus">164:g>101-07.
    29. Board FN: / Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). USA: The National Academies Press; 2002. [ / Book Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients)]
    30. Hoffman J: / Norms for fitness, performance, and health. USA: Human Kinetics, New Jersey; 2006.
    31. Glickman SG, Marn CS, Supiano MA, Dengel DR: g class="a-plus-plus">Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity.g> / J Appl Physiol 2004, g class="a-plus-plus">97:g>509-14. g/10.1152/japplphysiol.01234.2003">CrossRef
    32. Katrina K, King N, Hayes D: / Moving Away From Diets: Healing Eating Problems and Exercise Resistance. Texas, USA: Helm Publishing & Seminars; 2003.
    33. McNair D, Lorr M, Droppleman LF: / Profile of Mood States Manual, Book Profile of Mood States Manual. San Diego, CA: Educational and Industrial Testing Service; 1971.
    34. Gormally J, Black S, Daston S, Rardin D: g class="a-plus-plus">The assessment of binge eating severity among obese persons.g> / Addict Behav 1982, g class="a-plus-plus">7:g>47-5. g/10.1016/0306-4603(82)90024-7">CrossRef
    35. Bingham SA, Cassidy A, Cole TJ, Welch A, Runswick SA, Black AE, Thurnham D, Bates C, Khaw KT, Key TJ, / et al.: g class="a-plus-plus">Validation of weighed records and other methods of dietary assessment using the 24?h urine nitrogen technique and other biological markers.g> / Br J Nutr 1995, g class="a-plus-plus">73:g>531-50. g/10.1079/BJN19950057">CrossRef
    36. Hebert JR, Clemow L, Pbert L, Ockene IS, Ockene JK: g class="a-plus-plus">Social Desirability Bias in Dietary Self-Report May Compromise the Validity of Dietary-Intake Measures.g> / Int J Epidemiol 1995, g class="a-plus-plus">24:g>389-98. g/10.1093/ije/24.2.389">CrossRef
    37. Ahern GP: g class="a-plus-plus">Activation of TRPV1 by the satiety factor oleoylethanolamide.g> / J Biol Chem 2003, g class="a-plus-plus">278:g>30429-0434. g/10.1074/jbc.M305051200">CrossRef
    38. Aviello G, Matias I, Capasso R, Petrosino S, Borrelli F, Orlando P, Romano B, Capasso F, Di Marzo V, Izzo AA: g class="a-plus-plus">Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice.g> / J Mol Med-Jmm 2008, g class="a-plus-plus">86:g>413-22. g/10.1007/s00109-008-0305-7">CrossRef
    39. Capasso R, Matias I, Lutz B, Borrelli F, Capasso F, Marsicano G, Mascolo N, Petrosino S, Monory K, Valenti M, / et al.: g class="a-plus-plus">Fatty acid amide hydrolase controls mouse intestinal motility in vivo.g> / Gastroenterology 2005, g class="a-plus-plus">129:g>941-51. g/10.1053/j.gastro.2005.06.018">CrossRef
    40. Thomas DM, Bouchard C, Church T, Slentz C, Kraus WE, Redman LM, Martin CK, Silva AM, Vossen M, Westerterp K, Heymsfield SB: / Why do individuals not lose more weight from an exercise intervention at a defined dose?. Obes Rev: An energy balance analysis; 2012.
    41. King NA, Horner K, Hills AP, Byrne NM, Wood RE, Bryant E, Caudwell P, Finlayson G, Gibbons C, Hopkins M, / et al.: g class="a-plus-plus">Exercise, appetite and weight management: understanding the compensatory responses in eating behaviour and how they contribute to variability in exercise-induced weight loss.g> / Brit J Sport Med 2012, g class="a-plus-plus">46:g>315-22. g/10.1136/bjsm.2010.082495">CrossRef
    42. Wadden TA, Foster GD, Sarwer DB, Anderson DA, Gladis M, Sanderson RS, Letchak RV, Berkowitz RI, Phelan S: g class="a-plus-plus">Dieting and the development of eating disorders in obese women: results of a randomized controlled trial.g> / Am J Clin Nutr 2004, g class="a-plus-plus">80:g>560-68.
    43. Sherwood NE, Jeffery RW, Wing RR: g class="a-plus-plus">Binge status as a predictor of weight loss treatment outcome.g> / Int J Obes Relat Metab Disord 1999, g class="a-plus-plus">23:g>485-93. g/10.1038/sj.ijo.0800846">CrossRef
    44. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, Bluck L, Coward A, Hendrickx H: g class="a-plus-plus">Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.g> / Br J Nutr 2009, g class="a-plus-plus">101:g>886-94. g/10.1017/S0007114508047727">CrossRef
    45. Wightman EL, Haskell CF, Forster JS, Veasey RC, Kennedy DO: g class="a-plus-plus">Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo-controlled, crossover investigation.g> / Hum Psychopharmacol 2012, g class="a-plus-plus">27:g>177-86. g/10.1002/hup.1263">CrossRef
    46. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H: g class="a-plus-plus">Wide distribution of [3?H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue.g> / Carcinogenesis 1998, g class="a-plus-plus">19:g>1771-776. g/10.1093/carcin/19.10.1771">CrossRef
    47. Paladini AC, Marder M, Viola H, Wolfman C, Wasowski C, Medina JH: g class="a-plus-plus">Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds.g> / J Pharm Pharmacol 1999, g class="a-plus-plus">51:g>519-26. g/10.1211/0022357991772790">CrossRef
    48. Adachi N, Tomonaga S, Tachibana T, Denbow DM, Furuse M: g class="a-plus-plus">(-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain.g> / Eur J Pharmacol 2006, g class="a-plus-plus">531:g>171-75. g/10.1016/j.ejphar.2005.12.024">CrossRef
    49. Vignes M, Maurice T, Lante F, Nedjar M, Thethi K, Guiramand J, Recasens M: g class="a-plus-plus">Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).g> / Brain Res 2006, g class="a-plus-plus">1110:g>102-15. g/10.1016/j.brainres.2006.06.062">CrossRef
    50. Steptoe A, Gibson EL, Vuononvirta R, Williams ED, Hamer M, Rycroft JA, Erusalimsky JD, Wardle J: g class="a-plus-plus">The effects of tea on psychophysiological stress responsivity and post-stress recovery: a randomised double-blind trial.g> / Psychopharmacology (Berl) 2007, g class="a-plus-plus">190:g>81-9. g/10.1007/s00213-006-0573-2">CrossRef
  • 作者单位:Gerald T Mangine (1)
    Adam M Gonzalez (1)
    Adam J Wells (1)
    William P McCormack (1)
    Maren S Fragala (1)
    Jeffrey R Stout (1)
    Jay R Hoffman (1)

    1. Sport and Exercise Science, University of Central Florida, 4000 Central Florida Blvd, Orlando, FL, 32816, USA
文摘
Background A dietary supplement containing a blend of 170?mg of N-oleyl-phosphatidylethanolamine (NOPE) and 100?mg of epigallocatechin-3-gallate (EGCG) has been shown to improve compliance to low caloric diets. Considering the cost of dietary ingredients, many manufacturers attempt to determine the lowest efficacious dose. Thus, the purpose of this study was to evaluate the efficacy of 8-weeks of supplementation with a daily intake of 120?mg of NOPE and 105?mg of EGCG in conjunction with a low caloric diet and regular, moderate exercise on dietary compliance in healthy, overweight adults. An additional purpose was to examine the effect of this supplement/diet/exercise paradigm on changes in body composition, sensation of appetite, mood and severity of binge eating. Methods Fifty healthy, overweight (BMI-gt;-5?m·kg2) men (15) and women (35) (SUP; n--5; 32.7?±-3.75 y; BMI--3.4?±-.2; PLA; n--5, 34.3?±-2.7?years; BMI--3.2?±-.8) were recruited for a double-blind, placebo controlled study. Each volunteer was randomly assigned to either the supplement (SUP; n--5) or placebo group (PLA; n--5). Based upon a self-reported 3-day dietary recall all volunteers were recommended a 500?kcal or 30% (maximum of 1000?kcal) reduction in caloric intake. Volunteers were also encouraged to exercise 30?minutes per day, three times per week. Results Subjects in SUP were significantly more compliant (x 2--.86, p--.049) in maintaining a low caloric diet at week 4, but this was not able to be maintained through the 8-week study. In addition, a significant difference in mood, feelings of fatigue and confusion were noted between the groups at week 4, but again not maintained by week 8 where only feelings of tension were improved. No differences between groups (p-gt;-.05) were observed for body mass, body composition, feelings of hunger, and binge eating after eight weeks. Conclusion Supplementing with a combination of 120?mg of NOPE and 105?mg of EGCG does appear to enhance compliance to a low caloric diet and improve mood for 4 –weeks, but loses its effectiveness by week 8.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700